SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-24-028057 from Aeterna Zentaris Inc. (CSCI) (CIK 0001113423) (CSCIF)

Aeterna Zentaris Inc. (CSCI) (CIK 0001113423)
Date: July 16, 2024 · CIK: 0001113423 · Accession: 0001493152-24-028057

AI Filing Summary & Sentiment

File numbers found in text: 001-38064

Referenced dates: July 5, 2024

Date
July 16, 2024
Author
R. Saks
Form
CORRESP
Company
Aeterna Zentaris Inc. (CSCI) (CIK 0001113423)

Letter

Norton Rose Fulbright US LLP

1301 Avenue of the Americas

New York, NY 10019-6022 United States

Direct line +1 212-318-3151

Scott.Saks@nortonrosefulbright.com

Tel +1 212 318 3000

Fax +1 212 408 5100

nortonrosefulbright.com

July 16, 2024

FILED VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F Street, N.E.

Washington, D.C. 20549

Attention: Tara Harkins

Eric Atallah

Re: Aeterna Zentaris Inc.

Form 20-F for Fiscal Year Ended December 31, 2023

File No. 001-38064

Ladies and Gentlemen:

On behalf of Aeterna Zentaris Inc. (the “Company”), we are responding to the comment of the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) conveyed in the Staff’s Comment Letter, dated July 5, 2024 (the “Comment Letter”), with respect to the Company’s Annual Report on Form 20-F for Fiscal Year Ended December 31, 2023 (the “Annual Report”) filed with the Commission by the Company via EDGAR on March 27, 2024. In connection with this response letter to the Comment Letter (the “Response Letter”), the Company has filed with the Commission via EDGAR Amendment No. 1 to the Annual Report on Form 20-F/A (the “Amendment”), which has been revised to reflect the Company’s responses to the Staff comment.

For ease of review, we have set forth the Staff’s comment below in bold italics type followed by the Company’s response thereto.

Form 20-F for Fiscal Year Ended December 31, 2023

Exhibits

1. We note that your officers’ Section 906 certifications furnished in Exhibits 13.1 and 13.2 pursuant to Rule 13a-14(b) of the Exchange Act refer to the year ended December 31, 2021 rather than for the year ended December 31, 2023. Please file a full amendment to your Form 20-F which includes corrected and currently dated Section 906 certifications.

Response: The Company respectfully acknowledges and has complied with the Staff’s comment by filing the full Amendment which includes corrected and currently dated Section 906 certifications. See Exhibits 13.1 and 13.2 furnished with the Amendment. The Company has also included new Section 302 Certifications and accountant consents as required by the rules and regulations of the Commission. See Exhibits 12.1, 12.2, 15.1 and 15.2 filed with the Amendment.

* * *

United States Securities and Exchange Commission

July 16, 2024

Page 2

We hope that the foregoing response and corresponding revisions to Exhibits 13.1 and 13.2 furnished with the full Amendment are responsive to the Staff’s comments. Please do not hesitate to contact the undersigned, Scott R. Saks, of Norton Rose Fulbright US LLP, counsel to the Company, at (212) 318-3151 or at scott.saks@nortonrosefulbright.com, or my colleague, Juan Felipe Velasquez, at (713) 651-5637 or at juan.felipe.velasquez@nortonrosefulbright.com, with any questions or comments.

Very Truly Yours
/s/ Scott
R. Saks

Show Raw Text
CORRESP
1
filename1.htm

  Norton Rose Fulbright US LLP

  1301 Avenue of the Americas

  New York, NY 10019-6022 United States

  Direct line +1 212-318-3151

  Scott.Saks@nortonrosefulbright.com

  Tel +1 212 318 3000

  Fax +1 212 408 5100

  nortonrosefulbright.com

July
16, 2024

FILED
VIA EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, N.E.

Washington,
D.C. 20549

  Attention:
  Tara Harkins

  Eric Atallah

 Re: Aeterna
                                            Zentaris Inc.

    Form
                                            20-F for Fiscal Year Ended December 31, 2023

    File
                                            No. 001-38064

Ladies
and Gentlemen:

On
behalf of Aeterna Zentaris Inc. (the “Company”), we are responding to the comment of the staff (the “Staff”)
of the U.S. Securities and Exchange Commission (the “Commission”) conveyed in the Staff’s Comment Letter, dated
July 5, 2024 (the “Comment Letter”), with respect to the Company’s Annual Report on Form 20-F for Fiscal Year
Ended December 31, 2023 (the “Annual Report”) filed with the Commission by the Company via EDGAR on March 27, 2024.
In connection with this response letter to the Comment Letter (the “Response Letter”), the Company has filed with
the Commission via EDGAR Amendment No. 1 to the Annual Report on Form 20-F/A (the “Amendment”), which has been revised
to reflect the Company’s responses to the Staff comment.

For
ease of review, we have set forth the Staff’s comment below in bold italics type followed by the Company’s response thereto.

Form
20-F for Fiscal Year Ended December 31, 2023

Exhibits

1. We
                                            note that your officers’ Section 906 certifications furnished in Exhibits 13.1 and
                                            13.2 pursuant to Rule 13a-14(b) of the Exchange Act refer to the year ended December 31,
                                            2021 rather than for the year ended December 31, 2023. Please file a full amendment to your
                                            Form 20-F which includes corrected and currently dated Section 906 certifications.

Response:
The Company respectfully acknowledges and has complied with the Staff’s comment by filing the full Amendment which includes corrected
and currently dated Section 906 certifications. See Exhibits 13.1 and 13.2 furnished with the Amendment. The Company has also included
new Section 302 Certifications and accountant consents as required by the rules and regulations of the Commission. See Exhibits 12.1,
12.2, 15.1 and 15.2 filed with the Amendment.

*
* *

    United States Securities and Exchange Commission

July
                                            16, 2024

Page 2

We
hope that the foregoing response and corresponding revisions to Exhibits 13.1 and 13.2 furnished with the full Amendment are responsive
to the Staff’s comments. Please do not hesitate to contact the undersigned, Scott R. Saks, of Norton Rose Fulbright US LLP, counsel
to the Company, at (212) 318-3151 or at scott.saks@nortonrosefulbright.com, or my colleague, Juan Felipe Velasquez, at (713) 651-5637
or at juan.felipe.velasquez@nortonrosefulbright.com, with any questions or comments.

    Very Truly Yours

    /s/ Scott
    R. Saks

    Scott R. Saks

    cc:
    Giuliano
    La Fratta (Aeterna Zentaris Inc.)

    Juan
    Felipe Velasquez (Norton Rose Fulbright US LLP)

Norton
                                            Rose Fulbright US LLP is a limited liability partnership registered under the laws of Texas.

Norton
Rose Fulbright US LLP, Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright Canada LLP and Norton Rose Fulbright
South Africa Inc are separate legal entities and all of them are members of Norton Rose Fulbright Verein, a Swiss verein. Norton Rose
Fulbright Verein helps coordinate the activities of the members but does not itself provide legal services to clients. Details of each
entity, with certain regulatory information, are available at nortonrosefulbright.com.